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OBJECTIVE—Parental obesity is a risk factor for offspring
obesity. It is unclear whether parental obesity also confers risk
for obesity-associated conditions (e.g., a proinflammatory or
prothrombotic state) in the absence of offspring obesity.
RESEARCH DESIGN AND METHODS—We compared con-
centrations of multiple biomarkers representing distinct biolog-
ical pathways (C-reactive protein [CRP], aldosterone, renin,
B-type natriuretic peptide, NH2-terminal proatrial natriuretic
peptide, fibrinogen, and plasminogen activator inhibitor-1) in
nonobese Framingham Offspring Study participants with no
parents (n  665), one parent (n  488), or two parents (n 
119) with obesity (BMI 30 kg/m2).
RESULTS—Nonobese offspring with both parents with obesity
had higher CRP levels (median 2.16 mg/l) than offspring with one
parent (1.58 mg/l) or no parents (1.35 mg/l) with obesity. After
multivariable adjustment, a nonlinear relationship with parental
obesity became evident: compared with those without parental
obesity, CRP levels were higher in offspring with two obese
parents (P 0.04) but not in offspring with only one obese parent
(P  0.76). Renin levels were more linearly related to parental
obesity status, being significantly higher in offspring with one
parent (P  0.04) or two parents (P  0.09) with obesity (P 
0.02 for trend). The other systemic biomarkers did not vary
according to parental obesity status (all P  0.05).
CONCLUSIONS—Our findings suggest that offspring with a
high risk of developing obesity have an altered biomarker profile,
characterized by systemic inflammation and increased neurohor-
monal activity, even in the absence of obesity. This is consistent
with the notion that parental obesity may confer an increased
susceptibility to other adiposity-associated traits. Diabetes 58:
134–137, 2009
Obesity is highly prevalent in the U.S. (1) andpredisposes to metabolic and cardiovasculardiseases (2). Previous studies have docu-mented that excess adiposity is associated with
concomitant alterations of several biological pathways, as
reflected by the presence of a prothrombotic state (3,4),
neurohormonal activation (5,6), and systemic inflamma-
tion (7,8).
Obesity clusters in families, and parental obesity sub-
stantially increases the risk of obesity in offspring (9). It is,
however, less clear whether parental obesity also confers
a greater risk for developing a proinflammatory or pro-
thrombotic state, a natriuretic handicap, or increased
neurohormonal activation in offspring and whether these
conditions may even antedate the occurrence of obesity in
these individuals. One way to approach this question is to
compare biomarker levels that represent the above-
mentioned pathways in nonobese offspring with versus
without obese parents.
To the best of our knowledge, no previous study has
related circulating levels of a broad panel of biomarkers
in nonobese offspring to parental obesity status in a
community-based setting. We hypothesized that nonobese
offspring with obese parents would have higher levels of
C-reactive protein (CRP), renin and aldosterone, plasmin-
ogen activator inhibitor (PAI)-1, and fibrinogen but lower
levels of B-type natriuretic peptide (BNP) and NH2-termi-
nal proatrial natriuretic peptide (NT-ANP) than offspring
without parental obesity.
RESEARCH DESIGN AND METHODS
A detailed description of the study sample is available in an online appendix
(available at http://dx.doi.org/10.2337/db08-0918). Participants of the Framing-
ham Offspring cohort who were nonobese (BMI 30 kg/m2), were free of
prevalent cardiovascular disease at examination cycle 6 (1995–1998), and had
both parents in the original cohort were eligible for the present analysis (N 
1,272). Offspring who did not have both parents in the original cohort were
older and had higher systolic blood pressure and lower total cholesterol
levels.
Clinical evaluation and biomarker measurements. Participants under-
went a physical examination, anthropometry, laboratory assessment of car-
diovascular risk factors, and a medical history at each Framingham Heart
Study visit (approximately every 4 years). We analyzed seven biomarkers that
have been previously associated with adiposity-related traits or with obesity in
our cohort. Details of the different biomarker assays are provided in the online
appendix.
Statistical analysis. Baseline characteristics in Table 1 and biomarker
concentrations in Table 2 were compared using ordinary linear (normally
distributed continuous traits) and logistic (binary traits) regression models as
well as median regression models (for continuous traits that were not
normally distributed). For the following analyses, biomarkers were natural
logarithmically transformed for better symmetry of distributions. Biomarker
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concentrations among offspring of obese parents versus offspring of nonobese
parents were compared using generalized estimating equation models (ac-
counting for relatedness among study participants) adjusting for relevant
covariates among offspring (age, sex, BMI, systolic and diastolic blood
pressure, hypertension treatment, diabetes, total/HDL cholesterol, and smok-
ing—factors known to influence systemic biomarkers). Parental obesity was
defined as BMI 30 kg/m2 at any time over a life course as determined by
longitudinal examinations of the original cohort of the Framingham Heart
Study. We chose this definition because individuals become obese at different
ages, but once they are obese, the condition is relatively stable (10). Parental
obesity was modeled as a categorical variable (0, 1, and 2 parents with
obesity) with 0 parents serving as the referent group.
In additional analyses, we evaluated whether those biomarkers that were
related to parental obesity in the primary analyses might be important
mediators of the effect of parental obesity on offspring BMI. First, we
developed a multivariable model with offspring BMI as the dependent variable
and age, sex, smoking status, physical activity index, and caloric intake as the
covariates. Next, we analyzed whether parental obesity was significantly
related to offspring BMI in the multivariable model using parental obesity as
the predictor variable. Third, we omitted the parental obesity variable from
the model and added the biomarkers found to be significantly associated with
parental obesity in our primary analyses into the multivariable model as the
predictor variables, with BMI serving as the dependent variable. Finally, we
analyzed whether the regression coefficient for parental obesity (for predict-
ing offspring BMI) was attenuated upon adjustment for the significant
biomarker by adding both the biomarker and the parental obesity variable
simultaneously into the multivariable model predicting offspring BMI.
The significance level of the attenuation of the regression coefficient was
tested using a nonparametric bootstrap with 1,999 replications (11). Thus, we
evaluated the following models predicting offspring BMI: 1) clinical covariates
and parental obesity; 2) clinical covariates and biomarker; and 3) clinical
covariates, parental obesity, and any biomarker related to both parental
obesity in the primary analysis and offspring BMI in model 2. For those
offspring biomarkers significantly related to parental obesity, we evaluated in
secondary exploratory analyses whether paternal or maternal obesity was
related to those markers.
RESULTS
Association of parental obesity with offspring bi-
omarker levels. The clinical and anthropometric charac-
teristics of our sample are shown in Table 1. Table 2
displays offspring biomarker levels according to the num-
ber of parents with obesity. CRP demonstrated a nonlinear
association with parental obesity status. Offspring with
two obese parents displayed higher CRP levels than the
referent group without parental obesity (Table 2). This
association remained significant in multivariable-adjusted
models (Table 3). Offspring with a single obese parent did
not have higher CRP levels than the referent group.
Offspring with one obese parent had significantly higher
renin levels in multivariable-adjusted models (Table 3).
Offspring with two obese parents likewise had higher renin
levels than offspring without parental obesity, although the
association was borderline statistically significant in a
multivariable-adjusted model (P  0.091; Table 3). A trend
test was statistically significant (regression coefficient for
increase in log-renin per parent with obesity   0.09, P 
0.02).
In our sample, 335 participants had a history of maternal
and 391 of paternal obesity. In exploratory analyses,
neither maternal nor paternal obesity demonstrated statis-
tically significant relations to offspring log-CRP (  0.03
[95% CI 0.06 to 0.11] and   0.09 [0.001 to 0.18],
respectively) or offspring log-renin (  0.11 [0.005 to
0.22] and   0.07 [0.04 to 0.18], respectively); we cannot
exclude associations of a magnitude described by the 95%
CIs. The other biomarkers tested did not differ by parental
obesity status (Tables 2 and 3).
TABLE 1
Clinical characteristics of the study sample stratified by parental obesity status
No parent with obesity One parent with obesity Two parents with obesity P
n 665 488 119
Age (years) 57.8 9.4 57.2 9.4 56.5 10.5 0.13
Sex (% female) 53.8 52.7 51.3 0.56
Systolic blood pressure (mmHg) 126 19 126 19 126 19 0.66
Diastolic blood pressure (mmHg) 75 9 75  9 75 9 0.81
Antihypertensive treatment 21.5 21.3 22.7 0.87
Hypertension 34.4 34.2 34.5 0.97
BMI (kg/m²) 24.9  2.8 25.8  2.6 26.6 2.5 0.0001
Total cholesterol (mg/dl) 213 48 205 39 206  37 0.01
HDL cholesterol (mg/dl) 54 17 54 16 51 17 0.11
Current smoker 15.6 14.3 21.0 0.45
Diabetes 6.5 8.8 3.4 0.95
Data are means  SD or % unless otherwise indicated.
TABLE 2
Offspring biomarker levels stratified by parental obesity status
Biomarker concentration
No parents with obesity One parent with obesity Two parents with obesity P
CRP (mg/l) 1.35 (0.69, 3.51) 1.58 (0.78, 3.55) 2.16 (0.94, 5.12) 0.001
Aldosterone (ng/dl) 10 (7, 15) 10 (7, 14) 10 (7, 14) 1.00
Renin (mU/l) 12 (7, 20) 13 (7, 21) 13 (7, 23) 0.10
BNP (pg/ml) 9.3 (4, 19) 9.2 (4, 21) 8 (4, 17) 0.48
NT-ANP (pmol/l) 322 (230, 451) 325 (239, 463) 311 (193, 463) 0.56
Fibrinogen (mg/dl) 315 (285, 367) 316 (282, 368) 322 (283, 355) 0.75
PAI-1 (ng/ml) 18.8 (11.8, 28.8) 19.1 (12.9, 28.7) 19.8 (11.8, 29.4) 0.43
Data are median (quartile 1, quartile 3). Quartiles 1 and 3 refer to quartile cut points.
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Attenuation of relation of parental obesity to off-
spring BMI upon adjustment for offspring CRP or
renin. Parental obesity was a highly significant cross-
sectional correlate of offspring BMI ( regression coeffi-
cient per one parent with obesity   0.86 [SE 0.11], P 
0.0001). Likewise, offspring CRP was positively associated
with offspring BMI ( per 1-SD increase in logCRP  0.63
[SE 0.08], P 0.0001) in a multivariable-adjusted model.
The relation of parental obesity to offspring BMI was
significantly attenuated upon adjustment for CRP in the
model (  0.77 [SE 0.11], P 0.0001). The P value for this
attenuation was 0.0035 using bootstrap with 1,999 replica-
tions. In comparison, offspring renin levels were not
significantly associated with offspring BMI. Accordingly,
additional analyses were not performed with adjustment
for log-renin in the models predicting offspring BMI.
DISCUSSION
We analyzed seven systemic biomarker levels in 1,272
nonobese Framingham Offspring Study participants ac-
cording to the obesity status of their parents. Parental
obesity was defined as a BMI 30 kg/m2 at any time
over their life course based on biennial examinations of
the Framingham Heart Study.
Principal findings. CRP levels demonstrated a nonlinear
association with parental obesity status, being signifi-
cantly higher in nonobese offspring with two obese par-
ents but not in those with one obese parent. Plasma renin
levels were more linearly related to parental obesity
status; levels were higher in nonobese offspring with one
or two parents with obesity in multivariable-adjusted
models (P for trend  0.02). Levels of the other offspring
biomarkers (aldosterone, BNP, NT-ANP, fibrinogen, PAI-1)
did not differ by parental obesity status. These findings
indicate that parental obesity may confer risk of a proin-
flammatory state and neurohormonal activation even in
the absence of offspring obesity.
Comparison with the published literature
Obesity and CRP levels. Obesity is a proinflammatory
condition (12). Adults and children with obesity have
higher CRP levels (7,8). We are not aware of any study that
analyzed CRP levels in nonobese offspring of parents with
obesity. We observed higher CRP levels in offspring of
obese parents even in the absence of offspring obesity.
Also, we observed that parental obesity was positively
associated with offspring BMI and that this association
was attenuated upon adjustment for offspring CRP. These
observations indicate that parental obesity is associated
with a proinflammatory state in the offspring even in the
absence of offspring obesity. Furthermore, the propensity
for a proinflammatory state may, in part, mediate the
association of parental obesity with offspring BMI (off-
spring CRP attenuates the regression coefficient for paren-
tal obesity). In this context, previous studies have
demonstrated that CRP levels predict adiposity-related
conditions including diabetes (13) and the metabolic syn-
drome (14), indicating that a proinflammatory state is not
only a consequence of obesity but potentially also a
precursor of obesity or adiposity-related conditions. Our
observations are consistent with the notion that obesity
and inflammation share a common pathophysiological
basis that might be transmitted from obese parents to
offspring. Interestingly, a recent genome-wide association
study for CRP identified nine genetic variants within the
leptin receptor gene that reached genome-wide signifi-
cance for association with CRP levels (15). This finding
supports the concept that obesity and inflammation share
common genetic influences.
Obesity and the renin-angiotensin-aldosterone
system (RAAS). Several lines of evidence indicate an
activation of the RAAS in obesity, especially in obesity-
related hypertension (16). Clinical studies reported ele-
vated circulating concentrations of elements of the RAAS
in individuals with obesity (17). We observed higher renin
in nonobese offspring with one or two obese parents. Our
data indicate that offspring of obese parents have neuro-
hormonal activation, as evidenced by higher renin levels,
even in the absence of offspring obesity.
Obesity and natriuretic peptides. Obesity and BMI
have been inversely related to plasma levels of BNP and
NT-ANP in independent community-based studies (5,6)
and in patients with heart failure (18). However, in the
present analyses, we did not observe any association
between offspring BNP/NT-ANP levels and parental obe-
sity status.
Obesity and hemostasis. Previous studies documented
positive correlations between adiposity traits (e.g., BMI
and waist circumference) and PAI-1 in epidemiological (3)
and clinical (19) settings. In addition, higher PAI-1 has
been shown to predict the development of diabetes
(20,21). Likewise, fibrinogen was positively associated
with obesity-related measures (3,22). In euglycemic off-
spring of individuals with diabetes, elevated PAI-1 activity
(23) and increased fibrinogen levels (24) have been re-
ported. However, we did not observe any association
between offspring PAI-1 or fibrinogen and parental
obesity.
TABLE 3






One parent with obesity 0.01 (0.04) 0.76
Two parents with obesity 0.16 (0.08) 0.039
Aldosterone
One parent with obesity 0.05 (0.03) 0.14
Two parents with obesity 0.03 (0.06) 0.58
Renin
One parent with obesity 0.11 (0.06) 0.037
Two parents with obesity 0.15 (0.09) 0.091
BNP
One parent with obesity 0.08 (0.05) 0.13
Two parents with obesity 0.007 (0.08) 0.93
NT-ANP
One parent with obesity 0.05 (0.03) 0.10
Two parents with obesity 0.03 (0.05) 0.52
Fibrinogen
One parent with obesity 0.001 (0.01) 0.90
Two parents with obesity 0.005 (0.02) 0.81
PAI-1
One parent with obesity 0.04 (0.03) 0.23
Two parents with obesity 0.09 (0.05) 0.093
The regression coefficient () indicates the increase in log-biomarker
per parent with obesity. Thus, having two parents with obesity was
associated with an e  e0.16  1.17-fold increase in multivariable-
adjusted CRP levels relative to those with no parents with obesity.
Multivariable adjustment for age, sex, systolic and diastolic blood
pressure, antihypertensive treatment, total-to-HDL cholesterol ratio,
smoking, diabetes, and BMI.
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Strengths and limitations. The large community-based
design, standardized assessment of multiple cardiovascu-
lar risk factors, availability of a broad spectrum of biomar-
kers, and complete ascertainment of obesity in parents all
strengthen our investigation. However, some limitations
merit consideration. We focused on biomarkers represent-
ing key pathways (inflammation, neurohormonal activity,
and hemostasis) in obesity-associated conditions that
were available in our sample. Other biomarkers might also
be related to obesity but were not measured in our sample
at this examination. Overall, seven different biomarkers
were tested. We did not correct for multiple statistical
testing because all tests (and related hypotheses) were
specified a priori. However, we acknowledge that our
findings need confirmation in other investigations. Also,
the cross-sectional design of our study precludes causal
interferences. All biomarkers were measured only at one
point in time. Intraindividual variability in biomarker lev-
els over time may have limited our ability to discern
associations of biomarkers with parental obesity. About
one-third of offspring had BNP levels below the detection
limit. We therefore also analyzed Tobit models, which
confirmed the lack of association between offspring BNP
levels and parental obesity status. However, the left trun-
cation of the BNP distribution might have resulted in a
random misclassification that may have reduced our
power to detect an association between BNP levels and
parental obesity status. The exclusion of offspring with
obesity at examination cycle 6 may have resulted in
excluding some very informative participants, but we
chose to do so because presence of obesity profoundly
affects several of the biomarkers evaluated. Finally, the
generalizability of our findings to other age-groups and
ethnicities is not clear because our sample was middle-
aged to elderly and almost exclusively white and of
European ancestry.
Conclusions. Nonobese offspring of parents with obesity
have an altered biomarker profile characterized by higher
renin and CRP levels. This is consistent with the concept
that obese parents transmit a susceptibility predisposing
to systemic inflammation and neurohormonal activation to
offspring that is detectable even in the absence or before
the development of offspring obesity.
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